Meek, B. AND J. Lipscomb. Gaining Acceptance for the use of in vitro Toxicity Assays and QIVIVE in Regulatory Risk Assessment. M Yoon, B Blaaauboer H clewell (ed.), TOXICOLOGY. Elsevier Science Ltd, New York, NY, 332:112-123, (2015).

KENYON, E. M., R. A. PEGRAM, C. R. EKLUND, AND J. C. LIPSCOMB. COMPARISON OF IN VIVO DERIVED AND SCALED IN VITRO METABOLIC RATE CONSTANTS FOR SOME VOLATILE ORGANIC COMPOUNDS (VOCS). Presented at Society of Toxicology (SOT) Annual Meeting, San Francisco, CA, March 11 - 15, 2012.

MAZUR, C. S., J. F. KENNEKE, J. HESS-WILSON, AND J. C. LIPSCOMB. Differences Between Human and Rat Intestinal and Hepatic Bisphenol-A Glucuronidation and the Influence of Alamethicin on In vitro Kinetic Measurements. DRUG METABOLISM AND DISPOSITION. American Society for Pharmacology and Experimental Therapeutics, Bethesda, MD, 38(12):2232-2238, (2010).

Lipscomb, J. AND G. L. Kedderis. Incorporating Human Interindividual Biotransformation Variance In Health Risk Assessment. The Science of The Total Environment (2002).

Lipscomb, J., L. Teuschler, J. Swartout, C. A. Striley, AND J. E. Snawder. Variance Of Microsomal Protein And Cytochrome P450 2E1 And 3A Forms In Adult Human Liver. (2003).

Snawder, J. E. AND J. Lipscomb. Interindividual Variance Of Cytochrome P450 Forms In Human HEPAtic Microsomes: Correlation Of Individual Forms With Xenobiotic Metabolism And Implications In Risk Assessment. Regulatory Toxicology and Pharmacology 32(2):200-209, (2000).

Kedderis, G. L. AND J. Lipscomb. Application Of In Vitro Biotransformation Data And Pharmacokinetic Modeling To Risk Assessment. TOXICOLOGY AND INDUSTRIAL HEALTH. Princeton Scientific Publishers, Princeton, NJ, 17(5-10): 315-321, (2001).